Darzalex IV
NDC 57894-505 · Janssen Biotech, Inc.
Generic nameDaratumumab
Dosage formINJECTION, SOLUTION, CONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)DARATUMUMAB
Strength100 mg/5mL
Pharmacologic classAntibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC]
Marketing categoryBLA
Packages
57894-505-05 — 1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-05) / 5 mL in 1 VIAL, SINGLE-DOSE
57894-505-20 — 1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-20) / 20 mL in 1 VIAL, SINGLE-DOSE
Billed under HCPCS
J9145 — Injection, daratumumab, 10 mg Medicare Part B payment limit (ASP + 6%): $73.77
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
57894-502 — Daratumumab, 57894-503 — daratumumab and hyaluronidase-fihj (human recombinant)